Greater Glasgow and Clyde Medicines

Restrictions:

The treatment of moderate to severe symptoms of uterine fibroids in adult women is restricted to the following MHRA advice:

• intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age who are not eligible for surgery or where surgery has failed
• treatment is to be initiated and supervised by a physician experienced in the diagnosis and treatment of uterine fibroids

Please refer to MHRA information prior to initiation.

BNF Link

Prescribing Notes:

• Ulipristal is licensed for use in women presenting up to 120 hours after unprotected intercourse for whom the insertion of an IUD is not acceptable. 
• Please follow the CoSRH guidance for appropriate use. 

BNF Link